Electromed (NYSE:ELMD) versus QT Imaging (NASDAQ:QTI) Financial Review

Electromed (NYSE:ELMDGet Free Report) and QT Imaging (NASDAQ:QTIGet Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Profitability

This table compares Electromed and QT Imaging’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Electromed 9.41% 12.44% 10.72%
QT Imaging N/A N/A -37.12%

Analyst Ratings

This is a summary of current recommendations and price targets for Electromed and QT Imaging, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed 0 0 0 0 N/A
QT Imaging 0 0 0 0 N/A

Earnings & Valuation

This table compares Electromed and QT Imaging”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Electromed $54.72 million 3.14 $5.15 million $0.50 39.66
QT Imaging $3.07 million 4.44 -$4.03 million N/A N/A

Electromed has higher revenue and earnings than QT Imaging.

Volatility and Risk

Electromed has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.09, suggesting that its share price is 109% less volatile than the S&P 500.

Institutional & Insider Ownership

40.8% of Electromed shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 12.7% of Electromed shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Electromed beats QT Imaging on 7 of the 9 factors compared between the two stocks.

About Electromed

(Get Free Report)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

About QT Imaging

(Get Free Report)

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.